KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $14.4 million.

  • Idexx Laboratories' Share-based Compensation fell 932.91% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.2 million, marking a year-over-year decrease of 506.04%. This contributed to the annual value of $60.3 million for FY2024, which is 93.07% up from last year.
  • Per Idexx Laboratories' latest filing, its Share-based Compensation stood at $14.4 million for Q3 2025, which was down 932.91% from $14.9 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Share-based Compensation registered a high of $15.9 million during Q3 2024, and its lowest value of $8.9 million during Q1 2021.
  • In the last 5 years, Idexx Laboratories' Share-based Compensation had a median value of $14.3 million in 2024 and averaged $13.2 million.
  • Per our database at Business Quant, Idexx Laboratories' Share-based Compensation surged by 3671.37% in 2022 and then tumbled by 932.91% in 2025.
  • Idexx Laboratories' Share-based Compensation (Quarter) stood at $9.7 million in 2021, then soared by 36.71% to $13.3 million in 2022, then rose by 14.64% to $15.2 million in 2023, then fell by 6.34% to $14.3 million in 2024, then rose by 1.23% to $14.4 million in 2025.
  • Its Share-based Compensation stands at $14.4 million for Q3 2025, versus $14.9 million for Q2 2025 and $14.6 million for Q1 2025.